Cardiovascular Systems PE Ratio 2006-2020 | CSII

Current and historical p/e ratio for Cardiovascular Systems (CSII) from 2006 to 2020. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Cardiovascular Systems PE ratio as of June 03, 2020 is 0.00.
Cardiovascular Systems PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2020-06-03 39.48 0.00
2020-03-31 35.21 $-0.31 0.00
2019-12-31 48.59 $-0.21 0.00
2019-09-30 47.52 $-0.10 0.00
2019-06-30 42.93 $-0.02 0.00
2019-03-31 38.66 $0.05 773.20
2018-12-31 28.49 $0.04 712.25
2018-09-30 39.14 $0.02 1957.00
2018-06-30 32.34 $0.05 646.80
2018-03-31 21.93 $-0.04 0.00
2017-12-31 23.69 $-0.10 0.00
2017-09-30 28.15 $-0.06 0.00
2017-06-30 32.23 $-0.06 0.00
2017-03-31 28.28 $-0.23 0.00
2016-12-31 24.21 $-0.87 0.00
2016-09-30 23.74 $-1.37 0.00
2016-06-30 18.38 $-1.72 0.00
2016-03-31 10.37 $-1.84 0.00
2015-12-31 15.12 $-1.49 0.00
2015-09-30 15.84 $-1.19 0.00
2015-06-30 26.45 $-1.04 0.00
2015-03-31 39.04 $-1.08 0.00
2014-12-31 30.08 $-1.06 0.00
2014-09-30 23.63 $-1.21 0.00
2014-06-30 31.16 $-1.24 0.00
2014-03-31 31.79 $-1.21 0.00
2013-12-31 34.29 $-1.18 0.00
2013-09-30 20.05 $-1.14 0.00
2013-06-30 21.20 $-1.11 0.00
2013-03-31 20.48 $-1.07 0.00
2012-12-31 12.55 $-1.01 0.00
2012-09-30 11.56 $-0.96 0.00
2012-06-30 9.79 $-0.92 0.00
2012-03-31 9.25 $-0.83 0.00
2011-12-31 9.85 $-0.75 0.00
2011-09-30 11.39 $-0.65 0.00
2011-06-30 14.56 $-0.71 0.00
2011-03-31 10.83 $-0.85 0.00
2010-12-31 11.66 $-1.14 0.00
2010-09-30 5.24 $-1.47 0.00
2010-06-30 4.48 $-1.62 0.00
2010-03-31 5.31 $-1.73 0.00
2009-12-31 4.59 $0.53 8.66
2009-09-30 7.27 $0.99 7.34
2009-06-30 7.71 $-2.28 0.00
2009-03-31 7.09 $-8.78 0.00
2008-12-31 9.30 $-13.90 0.00
2008-09-30 12.10 $-13.90 0.00
2008-06-30 13.50 $-14.80 0.00
2008-03-31 14.00 $8.60 1.63
2007-12-31 31.00 $8.70 3.56
2007-09-30 64.60 $8.70 7.43
2007-06-30 58.00 $11.10 5.23
2007-03-31 55.60 $-8.30 0.00
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.341B $0.248B
Cardiovascular Systems, Inc., formerly known as Replidyne Inc., is headquartered in Saint Paul, Minnesota. It is a medical device company focusing on developing and commercializing interventional treatment systems for vascular disease. Its initial product, the Diamondback 360? Orbital Atherectomy System, is a minimally invasive catheter system for the treatment of peripheral arterial disease; and a range of plaque types, including calcified vessel lesions. The Diamondback 360? removes soft and calcified plaque in plaque-lined vessels through the orbital rotation of a diamond grit coated offset crown. The company refined its `orbital` technology to address the growing market need of providing a safer more effective atherectomy device.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $163.830B 28.41
Medtronic (MDT) Ireland $130.331B 21.19
Stryker (SYK) United States $74.362B 24.14
Boston Scientific (BSX) United States $52.532B 24.70
Baxter (BAX) United States $46.146B 28.17
Lonza Group Ag (LZAGY) Switzerland $36.460B 0.00
Terumo (TRUMY) Japan $30.335B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $29.429B 0.00
Zimmer Biomet Holdings (ZBH) United States $26.519B 16.69
ResMed (RMD) United States $23.112B 36.47
Smith & Nephew SNATS (SNN) United Kingdom $18.370B 0.00
Sunny Optical Technology (SNPTF) China $15.252B 0.00
Bio-Rad Laboratories (BIO) United States $14.618B 66.54
Insulet (PODD) United States $11.765B 1165.63
DiaSorin S.p.A (DSRLF) Italy $10.630B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $8.366B 0.00
Perrigo (PRGO) Ireland $7.685B 13.75
Quidel (QDEL) United States $7.081B 55.64
Hill-Rom Holdings (HRC) United States $6.783B 19.12
William Demant Holdings (WILYY) Denmark $6.670B 0.00
GN STORE NORD (GNNDY) Denmark $6.590B 34.05
Canopy Growth (CGC) Canada $5.662B 0.00
Haemonetics (HAE) United States $5.428B 32.60
ICU Medical (ICUI) United States $4.102B 29.92
GW Pharmaceuticals (GWPH) United Kingdom $3.935B 0.00
Neogen (NEOG) United States $3.757B 63.63
Agios Pharmaceuticals (AGIO) United States $3.602B 0.00
Envista Holdings (NVST) United States $3.430B 0.00
NuVasive (NUVA) United States $3.226B 25.90
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.985B 0.00
National Vision Holdings (EYE) United States $2.196B 37.99
TG Therapeutics (TGTX) United States $2.063B 0.00
AtriCure (ATRC) United States $1.801B 0.00
Aurora Cannabis (ACB) Canada $1.478B 0.00
Aphria (APHA) Canada $1.203B 0.00
NanoString Technologies (NSTG) United States $1.183B 0.00
MacroGenics (MGNX) United States $1.079B 0.00
Cerus (CERS) United States $1.051B 0.00
Phibro Animal Health (PAHC) United States $1.038B 20.70
InMode (INMD) Israel $0.992B 20.97
PetIQ (PETQ) United States $0.847B 24.46
Omeros (OMER) United States $0.813B 0.00
DFB Healthcare Acquisitions (AHCO) United States $0.768B 130.08
Quanterix (QTRX) United States $0.762B 0.00
OraSure Technologies (OSUR) United States $0.752B 151.38
VAREX IMAGING (VREX) United States $0.749B 18.59
Eagle Pharmaceuticals (EGRX) United States $0.718B 51.43
Zynex (ZYXI) United States $0.650B 65.23
Meridian Bioscience (VIVO) United States $0.645B 24.27
Lantheus Holdings (LNTH) United States $0.560B 11.26
Vapotherm (VAPO) United States $0.556B 0.00
LeMaitre Vascular (LMAT) United States $0.535B 30.49
Surmodics (SRDX) United States $0.517B 62.31
Owens & Minor (OMI) United States $0.481B 12.73
Repro-Med Systems (KRMD) United States $0.425B 357.00
BioLife Solutions (BLFS) United States $0.417B 146.00
Cytosorbents (CTSO) United States $0.376B 0.00
Utah Medical Products (UTMD) United States $0.373B 27.09
Viemed Healthcare (VMD) United States $0.324B 29.03
Organigram Holdings (OGI) Canada $0.316B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.285B 0.00
HEXO (HEXO) $0.267B 0.00
Female Health (VERU) United States $0.237B 0.00
InfuSystems Holdings (INFU) United States $0.236B 130.78
Chimerix (CMRX) United States $0.204B 0.00
Evolus (EOLS) United States $0.161B 0.00
Fonar (FONR) United States $0.158B 13.98
Chembio Diagnostics (CEMI) United States $0.155B 0.00
Bovie Medical (APYX) United States $0.150B 0.00
Rockwell Medical (RMTI) United States $0.146B 0.00
Exagen (XGN) United States $0.142B 0.00
Surface Oncology (SURF) United States $0.140B 0.00
United Health Products (UEEC) United States $0.137B 0.00
Liberty Health Sciences (LHSIF) Canada $0.135B 0.00
MTech Acquisition (KERN) United States $0.124B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.108B 0.00
United-Guardian (UG) United States $0.080B 18.62
Brainsway (BWAY) Israel $0.079B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.078B 0.00
Wound Management Technologies (SMTI) United States $0.074B 0.00
Nephros (NEPH) United States $0.070B 0.00
Capricor Therapeutics (CAPR) United States $0.069B 0.00
GUARDION HEALTH (GHSI) United States $0.044B 0.00
Trinity Biotech (TRIB) Ireland $0.033B 0.00
ImmuCell (ICCC) United States $0.032B 0.00
NF Energy Saving (BIMI) China $0.028B 0.00
FSD PHARMA INC (HUGE) Canada $0.022B 0.00
Akers Biosciences Inc (AKER) United States $0.017B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.014B 0.00
Myomo (MYO) United States $0.010B 0.00
Senestech (SNES) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00